Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-29

FDA Approved: SODIUM PHENYLACETATE AND SODIUM BENZOATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for sodium phenylacetate and sodium benzoate from Zydus Pharmaceuticals USA Inc., updating its regulatory status for use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium phenylacetate and sodium benzoate (sodium phenylacetate and sodium benzoate)

Snippet

SUPPL AP for SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM PHENYLACETATE AND SODIUM BENZOATE)